XML 58 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of Reserved Shares for Future Issuance

The Company has reserved shares of common stock for future issuances as follows:

 

 

 

December, 31

 

December, 31

 

 

2022

 

2021

Warrants to purchase common stock

 

77,842

 

77,842

Common stock options issued and outstanding

 

2,290,596

 

2,175,685

Common stock available for future grants

 

374,099

 

1,934,095

Restricted stock units issued and outstanding

 

1,247,059

 

394,750

Common stock available for ESPP

 

62

 

401,164

 

Schedule of Stock Option Activity

A summary of stock option activity is set forth below (in thousands, except share and per share data):

 

 

Number of
Shares
Underlying
Outstanding
Options

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate
Intrinsic
Value

Outstanding, December 31, 2021

2,175,685

 

$

9.27

 

8.7

 

$

2,856

Options granted

354,800

 

$

1.88

 

 

 

 

 

Options exercised

(57,654)

 

$

0.61

 

 

 

 

 

Options forfeited or cancelled

(182,235)

 

$

9.38

 

 

 

 

 

Outstanding, December 31, 2022

2,290,596

 

$

8.33

 

8.0

 

$

1

Shares exercisable December 31, 2022

1,605,804

 

$

9.54

 

7.6

 

$

-

Vested and expected to vest, December 31, 2022

2,290,596

 

$

8.33

 

8.0

 

$

1

Schedule of Restricted Stock Units

A summary of RSU activity is set forth below:

 

Number of
Shares
Underlying
Outstanding
Restricted Stock

 

Weighted Average Grant Date Fair Value

Unvested, December 31, 2021

394,750

 

$

5.17

Granted

1,485,629

 

$

2.57

Released

(535,122)

 

$

4.36

Forfeited or cancelled

(98,198)

 

$

3.05

Unvested, December 31, 2022

1,247,059

 

$

2.58

Summary of Stock-Based Compensation Expense

Total stock-based compensation expense recognized was as follows (in thousands):

 

 

Years Ended December 31,

 

2022

 

2021

Cost of goods sold

$

314

 

$

274

Sales and marketing

 

2,575

 

 

2,137

Research and development

 

44

 

 

136

General and administrative

 

4,045

 

 

4,270

Total

$

6,978

 

$

6,817

The above stock-based compensation expense related to the following equity-based awards (in thousands):

 

 

Years Ended December 31,

 

2022

 

2021

Stock options

$

3,909

 

$

6,722

RSU

 

2,727

 

 

95

ESPP

 

342

 

 

Total

$

6,978

 

$

6,817

Schedule of Fair Value of Stock Options Estimated Using Weighted-Average Assumptions The fair value of stock options was estimated using the following weighted-average assumptions:

 

Years Ended December 31,

 

2022

 

2021

Expected dividends

 

0%

 

 

0%

Expected volatility

 

70.8%-72.4%

 

 

72.8% - 78.0%

Risk-free interest rate

 

1.9%-4.2%

 

 

0.6% - 1.3%

Expected term

 

6 years

 

 

5 - 6 years